Shilling, Valerie http://orcid.org/0000-0002-5610-0321
Starkings, Rachel http://orcid.org/0000-0002-1947-018X
Jenkins, Valerie http://orcid.org/0000-0001-8939-0081
Cella, David http://orcid.org/0000-0002-9881-4541
Fallowfield, Lesley http://orcid.org/0000-0003-0577-4518
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Accepted: 26 February 2019
First Online: 18 March 2019
Compliance with ethical standards
:
: VS has received an honorarium from Bristol-Myers Squibb. RS declares no conflict of interest. VJ has received research grants from Novartis and Sanofi Aventis. DC has received research grants from Ipsen, Clovis, Novartis and has consulted for Pfizer, Novartis, Regeneration, Astellas, Abbvie. He is a member of the National Quality Forum Scientific Methods Panel. LF has received research grants from Boehringer Ingelheim, Novartis, Bristol-Myers Squibb and Amgen, consulted for AstraZeneca, Puma Biotechnology and Roche and received honoraria from Amgen, Teva, Boehringer Ingelheim, Voluntis Oncolia, Novartis, Astellas Pharma, Eisai and Exerpta Medica.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.